Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James Parslow

James Parslow is recorded as CFO and CEO at Xenetic Biosciences, Inc. (XBIO). The proxy statement of Xenetic Biosciences, Inc. reports total compensation of $481,168 for James Parslow in fiscal 2024, including a base salary of $378,378. Disclosed compensation is on record for 7 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Xenetic Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Xenetic Biosciences, Inc. (XBIO) $378,378 $481,168
2023 Xenetic Biosciences, Inc. (XBIO) $329,175 $433,732
2022 Xenetic Biosciences, Inc. (XBIO) $329,175 $473,990
2021 Xenetic Biosciences, Inc. (XBIO) $299,250 $520,809
2020 Xenetic Biosciences, Inc. (XBIO) $285,000 $359,412
2019 Xenetic Biosciences, Inc. (XBIO) $265,000 $387,820
2018 Xenetic Biosciences, Inc. (XBIO) $265,000 $287,595

Recent activity

No call appearances or filed executive changes recorded yet.